The protective role of nitric oxide in a neurotoxicant-induced demyelinating model

被引:54
作者
Arnett, HA
Hellendall, RP
Matsushima, GK
Suzuki, K
Laubach, VE
Sherman, P
Ting, JPY [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Immunol Microbiol, Chapel Hill, NC 27599 USA
[4] Univ Virginia, Hlth Sci Ctr, Dept Surg, Charlottesville, VA 22908 USA
[5] Glaxo Wellcome Inc, Res Inst, Dept Human Genet, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.4049/jimmunol.168.1.427
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Demyelination is often associated with acute inflammatory events involving the recruitment-activation of microglia/macrophage, astrocytes, and leukocytes. The ultimate role of inflammatory products in demyelinating disease and in the survival of oligodendrocytes, the myelin forming cells, is unresolved. The current study examines the role of inducible NO synthase (iNOS)-derived NO in a neurotoxicant-induced model of demyelination. NO levels were greatly elevated in the midline corpus callosum during demyelination in genetically intact C57BL/6 mice, and this NO was due solely to the induction of iNOS, as the correlates of NO were not found in mice lacking iNOS. C57BL/6 mice lacking iNOS exhibited more demyelination, but did not display an increased overall cellularity in the corpus callosum, attributable to an unimpeded microglia/macrophage presence. An enhanced course of pathology was noted in mice lacking iNOS. This was associated with a greater depletion of mature oligodendrocytes, most likely due to apoptosis of oligodendrocytes. Microglia and astrocytes did not undergo apoptosis; during treatment. Our results suggest a moderately protective role for NO during acute inflammation-association demyelination.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 52 条
  • [11] CHAO CC, 1992, J IMMUNOL, V149, P2736
  • [12] Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats
    Clark, RSB
    Kochanek, PM
    Schwarz, MA
    Schiding, JK
    Turner, DS
    Chen, MZ
    Carlos, TM
    Watkins, SC
    [J]. PEDIATRIC RESEARCH, 1996, 39 (05) : 784 - 790
  • [13] Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
    Cowden, WB
    Cullen, FA
    Staykova, MA
    Willenborg, DO
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) : 1 - 8
  • [14] Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis
    Cross, AH
    Keeling, RM
    Goorha, S
    San, M
    Rodi, C
    Wyatt, PS
    Manning, PT
    Misko, TP
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) : 145 - 153
  • [15] AMINOGUANIDINE, AN INHIBITOR OF INDUCIBLE NITRIC-OXIDE SYNTHASE, AMELIORATES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN SJL MICE
    CROSS, AH
    MISKO, TP
    LIN, RF
    HICKEY, WF
    TROTTER, JL
    TILTON, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2684 - 2690
  • [16] EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE CAUSES DELAYED NEUROTOXICITY IN PRIMARY MIXED NEURONAL-GLIAL CORTICAL CULTURES
    DAWSON, VL
    BRAHMBHATT, HP
    MONG, JA
    DAWSON, TM
    [J]. NEUROPHARMACOLOGY, 1994, 33 (11) : 1425 - 1430
  • [17] Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
    DeGroot, CJA
    Ruuls, SR
    Theeuwes, JWM
    Dijkstra, CD
    VanderValk, P
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (01) : 10 - 20
  • [18] Ding MZ, 1998, J IMMUNOL, V160, P2560
  • [19] EXPRESSION OF THE INDUCIBLE FORM OF NITRIC-OXIDE SYNTHASE BY REACTIVE ASTROCYTES AFTER TRANSIENT GLOBAL-ISCHEMIA
    ENDOH, M
    MAIESE, K
    WAGNER, J
    [J]. BRAIN RESEARCH, 1994, 651 (1-2) : 92 - 100
  • [20] Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940